In melanoma, the EMT-like switch in phenotype can be driven by environmental pressures such as changes in the cytokine milieu at the tumor site, e.g., due to inflammation (5), and drug treatments such as inhibition of oncogenic BRAF (6). The gene discussed is BRAF; the disease is neoplasm.